Bernengo MG, Quaglino P, Comessatti A, Ortoncelli M, Novelli M, Lisa F, Fierro MT. Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. Haematologica [Internet]. 2007Jun.1 [cited 2026Nov.15];92(6):784-9. Available from: https://haematologica.org/article/view/4472